ABSTRACT

Purpose:

To determine the incidence, risc factors and treatment results of retinopathy of premature (ROP) among premature infants followed in our clinic.

Methods:

The examination findings of premature infants followed in our clinic between December 2006 –August 2009 are evaluated. The incidence of ROP, its stage and the rate of infants who warranted treatment was determined following the grouping according to birth weight and gestational age. The hospital registrations of eighty-nine infants followed up in our neonatal unit are screened for respiratory distres syndrome (RDS), mechanical ventilation treatment, sepsis. In addition the treatment results and complications of Argon laser treatment are evaluated.

Results:

The mean gestational age and the mean birth weight of the 221 premature infants included in our study was 30.69±2.48 (23-36) weeks and 1513.75 ± 471.73 (700-3278) gr, respectively. ROP was detected in 33.5% (74/221) of premature infants followed up. Regarding the gestational age the incidence was highest among infants born before 28 weeks (54.90 %) and regarding the birth weight the incidence was highest in premature infants less than 1000gr (61.8%). Statistical analysis revealed a significant relationship between birth weight, gestational age and ROP (p

Conclusion:

As a multifactorial disease ROP composes a great risc of blindness for infants with small gestational age and low birth weight, however Argon laser treatment of eyes with ROP seems to be an effective and safe alternative.

References

1Quinn GE, Retinopathy of premature. In: Yanoff M, Duker JS eds. Ophthalmology, 2nd ed, chap 309. St Louis, Mosby, 2004

2Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Z,n A; International NO-ROP Group, Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate and high levels of development: implications for screening programs Pediatrics 2005,115

3zkan H, Köksal N, Premat&uumlre Retinopatisi G&uumlncel Pediatri 2005,2-24

4Arsan S, Premat&uumlre Retinopatisi T Klin Pediatri 2004,2-382

5Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology and American Association for Pediatric Ophthalmology and Strabismus, Screening Examination of Premature Infants for Retinopathy of Prematurity Pediatrics 2006,117-572

6An International Committee for the Classification of Retinopathy of Prematurity : The international classification of retinopathy of prematurity revisited, Arch Ophthalmol 2005,123-991

7Early Treatment for Retinopathy of Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial, Arch Ophthalmol 2003,121-1684

8Terry TL, Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each cyrstalline lens. Am J Ophthalmol 1942,25-203

9Phelps DL, An estimate of vision loss in the United States-1979. Pediatrics 1981,67-924

10Patz A, Hoeck Le, De La Cruz E, Studies on the effect of high oxygen adminstration in retrolental fibroplasia Am J Ophthalmol 1952,35-1248

11Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Coopreative Group. Ophthalmology 1991,98-1628

12Schalij –Delfos NE, Cats BP, Retinopathy of prematurity:the continuing threat to vision in preterm infants. Dutch survey from 1986-1994. Acta Ophthalmologica Scand 1997,75-72

13Kulaçoglu DN, Sertöz AD, Ates O, Baykal O, Premat&uumlre retinopatisinde risk fakt&oumlrleri ve tarama sonu&ccedillari. Ret-Vit 2005,13-33

14zcan E, Yenice , Kazokoglu H, Bavbek T, Toker E, zek E, Premat&uumlre Retinopatisi Gelisiminde Etkili Risk Fakt&oumlrleri ve Tarama Sonu&ccedillari Ret-Vit 2006,14-127

15Gültan E, Kutluk S, nder F, Arsan S, Kural G, Premat&uumlre Retinopatisi Gelismesinde Etkili Fakt&oumlrler Ret-Vit 1996,3-619

16ner A, zkiris A, Günes T, Karaküçük S, Premat&uumlre Retinopatisi: 2 Yillik Tarama Sonu&ccedillarimiz. Erciyes Tip Dergisi 2005,27-104

17Apil A, Vatansever H, Oba E ve ark. : Premat&uumlre bebeklerde retinopati insidansi ve retinopati saptanan g&oumlzlerde evre, zon iliskisi. T Oft Gaz. 2004,34-439

18Afrashi F, Erakgon T, Mentes J ve ark, Premat&uumlre bebeklerde premat&uumlre retinopatisi tarama sonu&ccedillari T Oft Gaz 2005,35-150

19Mutlu FM, Altinsoy HI, Mumcuoglu T, Kerimoglu H Kiliç S, Kul M, Sarici SU, Alpay F, Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey:frequency, outcomes and risc factor analysis. J Pediatr Ophtahlmol Srabismus 2008,45-291

20Shohat M, Reisner SH, Krikler R, Nissenkom I, Yassur Y, Ben-Sira I, Retinopathy of prematurity: Incidence and risc factors. Pediatrics 1983,72-159

21Arroe M, Peitersen B, Retinopathy of prematurity: Review of a seven-year period in a Danish neonatal intensive care unit. Acta Pediatr 1994,83-501

22Patz A, Hoeck LE, De La Cruz E, Studies on the effect of high oxygen administration in retrolental fibroplasia I. Nursery observations Am J Ophthalmol 1952,35-1248

23Flynn JT, Bancalari E, Bawol R, Goldberg R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E ve ark, Retinopathy of prematurity Arandomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology 1987,94-630

24Stout AU, Stout JT, Retinopathy of prematurity Pediatr Clin N Am 2003,50-77

25Cryotherapy for Retinopathy of Prematurity Cooperative Group, Multicentre trial for cryoherapy for retinopathy of prematurity: one year outcome-structure and function. Arch Ophthalmol 1990,108-1408

26Cryotherapy for Retinopathy of Prematurity Cooperative Group, Multicentre trial for cryoherapy for retinopathy of prematurity: ophthalmological outcome at 10 years. Arch Ophthalmol 2001,119-110

27STOP-ROP, Multicentre Study Group. Supplemental therapeutic oxygen for pretreshold retinopathy of prematurity. (STOP-ROP), a randomized controlled trial. I: Preliminary outcomes. Pediatrics 2000,105-295

28Pierce EA, Foley ED, Smith LEH, Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996,114-1219

29McNamara JA, Tasman W, Brown GC, Federman JL, Laser photocoagulation stage 3+ retinopathy of prematurity. Ophthalmolgy 1991,98-576

30Iverson DA, Trese MT, Orgel IK, Williams GA, Laser photocoagulation for treshold retinopathy of prematurity. Arch Ophthalmol 1991,109-1342

31Yaman A, Çetin E, Berk AT, Kaynak S, Premat&uumlr Retinopatisinde Tedavi Sonu&ccedillarimiz Ret-Vit 2004,12-122

Risc Factors, Screening and Treatment Results of Retinopathy of Premature

ABSTRACT

References